You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-MUC1 antibody [M9E7] (ab8322)

    CodeSizePriceAbpointsAvailability
        
     
    • -
    •   
    •   
    •   
    •  
    •   
    •   
    Updating...

    Overview

    Product name

    Anti-MUC1 antibody [M9E7]
    See all MUC1 products (45) ...

    Description

    Mouse monoclonal [M9E7] to MUC1

    Specificity

    Reacts with VNTR5 and VNTR20 recombinant unglycosylated fragments of MUC1 protein and underglycosylated MUC. It is directed to continuous MUC1 polypeptide epitopes without O-linked oligosaccharides present in natural MUC1. No cross reactivity with egg white avidin. Affinity = > 1.0 x108

    Tested applications

    Sandwich ELISA, ELISAmore details

    Cross reactivity

    Reacts with

    Human

    Immunogen

    High molecular weight (more than 300 kDa) glycoprotein from human milk-fat globule molecule

    Epitope

    Region of GVTSAPDTRPAPGSTAPPAHGVTSA synthetic peptide spanning the one repeat of VNTR extracellular portion of MUC1 molecule.

    Properties

    Form

    Liquid

    Storage instructions

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

    Storage buffer

    PBS with 0.1% sodium azide, pH 7.4

    Concentration

    Concentration information loading...

    Purity

    Protein A purified

    Primary antibody notes

    Detection of un-glycosylated and underglycosylated Mucin-1 Glycoprotein

    Clonality

    Monoclonal

    Clone number

    M9E7

    Myeloma

    x63-Ag8.653

    Isotype

    IgG

    Light chain type

    unknown

    Applications

    Show applications key

    Our Abpromise guarantee covers the use of ab8322 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Target

    Function

    The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.
    The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.

    Tissue specificity

    Expressed on the apical surface of epithelial cells, especially of airway passages, breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors, such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform 7 is expressed in tumor cells only.

    Sequence similarities

    Contains 1 SEA domain.

    Developmental stage

    During fetal development, expressed at low levels in the colonic epithelium from 13 weeks of gestation.

    Post-translational
    modifications

    Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat, ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures, while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation consists of high-mannose, acidic complex-type and hybrid glycans in the secreted form MUC1/SEC, and neutral complex-type in the transmembrane form, MUC1/TM.
    Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.
    Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.
    Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src-and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3beta-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation, phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.
    The N-terminal sequence has been shown to begin at position 24 or 28 (PubMed:11341784).

    Cellular localization

    Secreted; Cell membrane. Cytoplasm. Nucleus. On EGF and PDGFRB stimulation, transported to the nucleus through interaction with CTNNB1, a process which is stimulated by phosphorylation. On HRG stimulation, colocalizes with JUP/gamma-catenin at the nucleus and Apical cell membrane. Exclusively located in the apical domain of the plasma membrane of highly polarized epithelial cells. After endocytosis, internalized and recycled to the cell membrane. Located to microvilli and to the tips of long filopodial protusions.

    Target information above from: UniProt accessionP15941 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010).

    Information by UniProt

    Alternative names

    • Breast carcinoma associated antigen DF3 antibody
    • Breast carcinoma associated antigen DF3 antibody
    • Breast carcinoma-associated antigen DF3 antibody
    • CA 15 3 antibody
    • CA15 3 antibody
    • CA15 3 antigen antibody
    • CA15.3 antibody
    • Carcinoma associated mucin antibody
    • Carcinoma associated mucin antibody
    • Carcinoma-associated mucin antibody
    • CD 227 antibody
    • CD227 antibody
    • CD227 antibody
    • CD227 antigen antibody
    • DF3 antigen antibody
    • DF3 antigen antibody
    • EMA antibody
    • EMA antibody
    • Episialin antibody
    • Episialin antibody
    • Epithelial membrane antigen antibody
    • Epithelial membrane antigen antibody
    • Epithelial mucin tandem repeat sequence antibody
    • H23 antigen antibody
    • H23 antigen antibody
    • H23AG antibody
    • H23AG antibody
    • HGNC:7508 antibody
    • KL 6 antibody
    • KL6 antibody
    • MAM 6 antibody
    • MAM6 antibody
    • MUC 1 antibody
    • MUC 1 antibody
    • MUC-1 antibody
    • MUC-1/SEC antibody
    • MUC-1/X antibody
    • MUC1 antibody
    • MUC1-alpha antibody
    • MUC1-beta antibody
    • MUC1-CT antibody
    • MUC1-NT antibody
    • MUC1/ZD antibody
    • MUC1_HUMAN antibody
    • Mucin 1 antibody
    • Mucin 1 precursor antibody
    • Mucin 1 transmembrane antibody
    • Mucin-1 subunit beta antibody
    • Mucin1 antibody
    • Mucin1 antibody
    • Peanut reactive urinary mucin antibody
    • Peanut reactive urinary mucin antibody
    • Peanut-reactive urinary mucin antibody
    • PEM antibody
    • PEMT antibody
    • PEMT antibody
    • Polymorphic epithelial mucin antibody
    • Polymorphic epithelial mucin antibody
    • PUM antibody
    • PUM antibody
    • Tumor associated epithelial membrane antigen antibody
    • Tumor associated epithelial membrane antigen antibody
    • Tumor associated epithelial mucin antibody
    • Tumor associated mucin antibody
    • Tumor associated mucin antibody
    • Tumor-associated epithelial membrane antigen antibody
    • Tumor-associated mucin antibody
    see all

    References for Anti-MUC1 antibody [M9E7] (ab8322)

    ab8322 has not yet been referenced specifically in any publications.

    Publishing research using ab8322? Please let us know so that we can cite the reference in this datasheet

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"